• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

AXA Framlington Biotech Z INC

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider AXA Investment Managers UK Ltd
Fund Summary The aim of this Fund is to provide long-term capital growth.
SEDOL code BRJZVL2
ISIN GB00BRJZVL27
Fund code FMBZI
Managers Linden Thomson, Dani Saurymper
Manager Tenure 8 years
Morningstar Category Sector Equity Biotechnology
IMA Sector Specialist
Fund Size £377 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.82%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.1710
Buy Price £1.1710
Price Change -1.2647%
Price Date 30th March 2020
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 2nd March 2015
Fund Status OPEN

3-year Mean Monthly Return: 0.454%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance +19.37% -6.41% +9.64% -4.96% +12.26% +45.18% +63.71% +24.50% +7.60% +9.81%
Benchmark Performance
(Sector Equity Biotechnology)
+20.20% -7.96% +10.29% -3.96% +13.41%
Time Period Cumulative Benchmark Performance
(Sector Equity Biotechnology)
Fund Compared to Benchmark
1 day -1.26% -7.48% +6.21%
1 week -0.43% -5.12% +4.70%
1 month -3.06% -8.42% +5.36%
3 months -5.41% +5.86% -11.27%
6 months 8.43% -1.45% +9.87%
1 year -1.35% +3.18% -4.53%
3 years 2.96% +2.60% +0.35%
5 years 1.13% +13.50% -12.37%
10 years 14.43% +7.12% +7.31%
YTD -4.02% +1.00% -5.02%
Since inception 7.76% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Biogen Inc USA 8.52%
Amgen Inc USA 8.00%
Regeneron Pharmaceuticals Inc USA 6.60%
Gilead Sciences Inc USA 6.45%
Alexion Pharmaceuticals Inc USA 5.05%
Vertex Pharmaceuticals Inc USA 4.37%
Biomarin Pharmaceutical Inc USA 4.20%
Seattle Genetics Inc USA 3.36%
Incyte Corp USA 2.89%
Illumina Inc USA 2.70%

Currently unavailable